ETFs for the Next Biotech Takeover Targets
March 10, 2015 at 11:00 AM EDT
On the heels of last week’s news that AbbVie (NYSE: ABBV) will acquire cancer treatments maker Pharmacyclics (NasdaqGS: PCYC) for $21 billion, speculation is abound regarding the next potential takeover targets in the biotechnology industry. The biotech industry and the relevant exchange traded...
